Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf GroupNIVF -9.09%14 Debt-to-EBITDA is -0.17 as of Dec. 2025. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 478 Healthcare Providers & Services companies, NewGenIvf Group ranks better than 81.8% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for NewGenIvf Group's Debt-to-EBITDA or its related term are showing as below:
NIVF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.45 Med: 0.87 Max: 126.25
Current: 0.51
During the past 5 years, the highest Debt-to-EBITDA Ratio of NewGenIvf Group was 126.25. The lowest was 0.45. And the median was 0.87.
NIVF's Debt-to-EBITDA is ranked better than 81.8% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs NIVF: 0.51
NewGenIvf Group (NAS:NIVF) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
NewGenIvf Group Debt-to-EBITDA Related Terms
NewGenIvf Group Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for NewGenIvf Group's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NIVF vs RHEP, XCRT, SYRA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, NewGenIvf Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Dec. 2025) EBITDA data.
NewGenIvf Group (NIVF) has a Debt-to-EBITDA of -0.17 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on NewGenIvf Group. Over the past decade, NewGenIvf Group's Debt-to-EBITDA has ranged from 0.45 to 126.25. According to the industry distribution chart, NewGenIvf Group ranks #87 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 18.2%.
Is NewGenIvf Group's Debt-to-EBITDA too high?
NewGenIvf Group's current Debt-to-EBITDA is -0.17. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 126.25. Based on the distribution chart, NewGenIvf Group ranks #87 out of 478 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Debt-to-EBITDA compare to RHEP and XCRT?
According to the Healthcare Providers & Services industry distribution chart, NewGenIvf Group ranks #87 out of 478 companies for Debt-to-EBITDA. This places NewGenIvf Group in the top 18% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.25. Historically, NewGenIvf Group's own Debt-to-EBITDA has ranged from 0.45 to 126.25 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on NewGenIvf Group. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewGenIvf Group's current Debt-to-EBITDA is -0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Debt-to-EBITDA of -0.17. The current Debt-to-EBITDA is -0.17. NewGenIvf Group's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Debt-to-EBITDA is -0.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
